Lisata Therapeutics, Inc. (LSTA) Return on equity 2015–2024
Lisata Therapeutics, Inc. (LSTA) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-111.7%FY2024 · since FY2015: -668.7% → -111.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -111.7% | -44.1 pp |
| FY2023 | -67.6% | -24.3 pp |
| FY2022 | -43.3% | +38.2 pp |
| FY2021 | -81.4% | — |
| FY2015 | -668.7% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More LSTA financial trends
LSTA RevenueLSTA Net incomeLSTA Net marginLSTA Gross profitLSTA Gross marginLSTA Operating incomeLSTA Operating marginLSTA Operating cash flowLSTA Free cash flowLSTA Capital expendituresLSTA Stock buybacksLSTA Dividends paidLSTA Total assetsLSTA Total liabilitiesLSTA Shareholders’ equityLSTA overview →